APLT

Applied Therapeutics, Inc. Common Stock

0.10

USD

APLT Earnings Reports

Positive Surprise Ratio

APLT beat 15 of 27 last estimates.

56%

Next Report

Date of Next Report

Apr 13, 2026

Estimate for Q4 25 (Revenue/ EPS)

-$0.11

Implied change from Q3 25 (Revenue/ EPS)

-100.00%

-15.38%

Implied change from Q4 24 (Revenue/ EPS)

-133.33%

Applied Therapeutics, Inc. Common Stock earnings per share and revenue

On Nov 13, 2025, APLT reported earnings of -0.13 USD per share (EPS) for Q3 25, beating the estimate of -0.14 USD, resulting in a 8.96% surprise. Revenue reached 1.00 million, compared to an expected 340.00 thousand, with a 194.12% difference. The market reacted with a -70.33% price change (close before vs. close after earnings).

Looking ahead to Q4 25, 6 analysts forecast an EPS of -0.11 USD, with revenue projected to reach -- USD, implying an decrease of -15.38% EPS, and decrease of -100.00% in Revenue from the last quarter.

FAQ

What were Applied Therapeutics, Inc. Common Stock's earnings and revenue for the latest quarter Q3 2025?

For Q3 2025, Applied Therapeutics, Inc. Common Stock reported EPS of -$0.13, beating estimates by 8.96%, and revenue of $1.00M, 194.12% above expectations.

How did the market react to Applied Therapeutics, Inc. Common Stock's Q3 2025 earnings?

The stock price moved down -70.33%, changed from $0.91 before the earnings release to $0.27 the day after.

When is Applied Therapeutics, Inc. Common Stock expected to report next?

The next earning report is scheduled for Apr 13, 2026.

What are the forecasts for Applied Therapeutics, Inc. Common Stock's next earnings report?

Based on 6 analysts, Applied Therapeutics, Inc. Common Stock is expected to report EPS of -$0.11 and revenue of -- for Q4 2025.

Which companies are reporting earnings today?

Check FXEmpire's Earnings Calendar for today's list of reporting companies.